The Rapid Response™ COVID-19 Antigen Nasal Pen Test is a rapid in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleocapsid protein antigens from nasal secretions within seven (7) days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19 infection. This test is authorized for use at the Point of Care i.e., in patient care setting.
This test is also available in custom pack sizes including 1, 2, 5, 20 and 25 packs. Contact us for more information.
- Test device individually packaged in a foil pouch:
- Pen containing test strip and collection tip
- Pen cap containing sealed compartment with liquid (extraction buffer)
- Product insert
The Rapid Response™ COVID-19 Antigen Nasal Pen Test is a rapid in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleocapsid protein antigens from nasal secretions within seven (7) days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19 infection. This test is authorized for use at the Point of Care i.e., in patient care setting.
This test is also available in custom pack sizes including 1, 2, 5, 20 and 25 packs. Contact us for more information.
- Please note that certain products may only be available in specific regions; kindly consult with a sales representative for further information regarding product availability.
- The information provided on this website is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare professional regarding any medical concerns or conditions.
- Our products are intended for use as specified in the product documentation. It is important to carefully read and follow all instructions provided with the product.
Canada